Correction to: Gadobutrol: A Review in Contrast-Enhanced MRI and MRA.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Works matching IS 11732563 AND DT 2018 AND VI 38 AND IP 10
Results: 11
1
2
Successful Response to Osimertinib Rechallenge after Intervening Chemotherapy in an EGFR T790M-Positive Lung Cancer Patient.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 10, p. 983, doi. 10.1007/s40261-018-0691-8
- By:
- Publication type:
- Article
3
Cost Estimate of Immune-Related Adverse Reactions Associated with Innovative Treatments of Metastatic Melanoma.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 10, p. 967, doi. 10.1007/s40261-018-0690-9
- By:
- Publication type:
- Article
4
Direct and Indirect Costs of Immunoglobulin Replacement Therapy in Patients with Common Variable Immunodeficiency (CVID) and X-Linked Agammaglobulinemia (XLA) in Italy.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 10, p. 955, doi. 10.1007/s40261-018-0688-3
- By:
- Publication type:
- Article
5
Pharmacokinetics, Pharmacodynamics, and Safety of the Novel Calcimimetic Agent Evocalcet in Healthy Japanese Subjects: First-in-Human Phase I Study.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 10, p. 945, doi. 10.1007/s40261-018-0687-4
- By:
- Publication type:
- Article
6
Potential for Cost Saving with Iclaprim Owing to Avoidance of Vancomycin-Associated Acute Kidney Injury in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 10, p. 935, doi. 10.1007/s40261-018-0686-5
- By:
- Publication type:
- Article
7
Indications for Systemic Fluoroquinolone Therapy in Europe and Prevalence of Primary-Care Prescribing in France, Germany and the UK: Descriptive Population-Based Study.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 10, p. 927, doi. 10.1007/s40261-018-0684-7
- By:
- Publication type:
- Article
8
A Network Pharmacology-Based Analysis of Multi-Target, Multi-Pathway, Multi-Compound Treatment for Ovarian Serous Cystadenocarcinoma.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 10, p. 909, doi. 10.1007/s40261-018-0683-8
- By:
- Publication type:
- Article
9
Non-Compartmental Pharmacokinetics and Safety of Single-Dose Eldecalcitol (ED-71) in Healthy Chinese Adult Males.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 10, p. 901, doi. 10.1007/s40261-018-0682-9
- By:
- Publication type:
- Article
10
A Review on Imiquimod Therapy and Discussion on Optimal Management of Basal Cell Carcinomas.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 10, p. 883, doi. 10.1007/s40261-018-0681-x
- By:
- Publication type:
- Article
11
Identification of Somatic Disorders Related to Psychoactive Drug Use from an Inpatient Database in a French University Hospital.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 10, p. 977, doi. 10.1007/s40261-018-0679-4
- By:
- Publication type:
- Article